Back
Perspective Therapeutics Stock Predictions
Sponsored
CATX
Sponsored
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
CATX
Perspective Therapeutics
Last Price:
13.26
Seasonality Move:
-10.19%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Perspective Therapeutics Stock Forecast
- Over the next 52 weeks, Perspective Therapeutics has on average historically risen by 28.3% based on the past 20 years of stock performance.
- Perspective Therapeutics has risen higher in 6 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
-
Is Perspective Therapeutics Stock Undervalued?
The current Perspective Therapeutics [CATX] share price is $13.23. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal. - CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Perspective Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Perspective Therapeutics has on average historically risen by 28.3% based on the past 20 years of stock performance.
Perspective Therapeutics Stock Rating
Sell
31
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics overpriced?
- Perspective Therapeutics has risen higher in 6 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
Perspective Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com
52-Week Data
52-Week High:
19.05
52-Week Low:
2.20
Prediction Charts
Market Cap:
892.07M
Price in USD:
13.23
Volume:
4.15M
Beta:
1.34
Technical Analysis
SMA50:
13.76
SMA100:
13.70
SMA200:
11.32
52-Wk Change:
341%
Stock Predictions
-
Is Perspective Therapeutics stock public?
Yes, Perspective Therapeutics is a publicly traded company. -
What is the Perspective Therapeutics stock quote today?
The Perspective Therapeutics stock price is 13.23 USD today. -
How to buy Perspective Therapeutics stock online?
You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-3 | 15.55 | 14.18 | 15.94 | 13.95 |
Sep-4 | 14.12 | 14.98 | 15.03 | 14.04 |
Sep-5 | 15.00 | 15.44 | 15.77 | 14.86 |
Sep-6 | 15.57 | 15.26 | 15.65 | 14.51 |
Sep-9 | 15.35 | 15.61 | 15.98 | 15.26 |
Sep-10 | 15.67 | 15.82 | 16.31 | 15.50 |
Sep-11 | 15.63 | 15.65 | 15.86 | 15.21 |
Sep-12 | 15.73 | 15.84 | 16.19 | 15.48 |
Sep-13 | 16.02 | 15.10 | 16.02 | 14.90 |
Sep-16 | 15.20 | 13.12 | 15.28 | 12.95 |
Sep-17 | 13.19 | 13.32 | 13.43 | 12.89 |
Sep-18 | 13.37 | 13.35 | 13.99 | 13.28 |
Sep-19 | 13.96 | 13.47 | 14.19 | 13.34 |
Sep-20 | 13.42 | 13.23 | 13.90 | 13.16 |
Perspective Therapeutics Earnings
Perspective Therapeutics Earnings Report: Per Share Perspective Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Perspective Therapeutics Forecast Revenue Growth
Perspective Therapeutics Stock Analysis: Historical quarterly revenues per share for Perspective Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.